MedTrace Logo

Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils

NCT01577056 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-04-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether fish oil supplementation is effective in the treatment of abnormal fat metabolism in subjects with elevated cholesterolaemia.

Conditions

  • Hypertriglyceridaemia
  • Familial Hypercholesterolaemia

Interventions

DIETARY_SUPPLEMENT

Fish oil capsule

4g Omega capsule for 12 weeks

DRUG

HMG Coenzyme reductase

All FH subjects are on standard statin treatment during study period

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • The University of Western Australia

    lead OTHER

Principal Investigators

  • Dick Chan, Phd · The University of Western Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-12-31
Completion
2014-03-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01577056 on ClinicalTrials.gov